Pettee Investors’s AbbVie ABBV Stock Holding History

Pettee Investors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.11M	Hold	12,370	–	–	1.53%	16
2026 Q1	$2.61M	Hold	12,370	–	–	1.35%	20
2025 Q4	$2.83M	Sell	12,370 -1,625	-12%	-$370K	1.59%	15
2025 Q3	$3.24M	Sell	13,995 -7,580	-35%	-$1.54M	1.78%	12
2025 Q2	$4M	Sell	21,575 -487	-2%	-$90.5K	2.4%	8
2025 Q1	$4.62M	Buy	22,062 +12,052	+120%	+$2.34M	2.75%	6
2024 Q4	$1.78M	Hold	10,010	–	–	0.9%	35
2024 Q3	$1.98M	Sell	10,010 -255	-2%	-$47.6K	0.96%	35
2024 Q2	$1.76M	Sell	10,265 -23,550	-70%	-$3.9M	0.85%	44
2024 Q1	$6.16M	Hold	33,815	–	–	2.61%	6
2023 Q4	$5.24M	Sell	33,815 -487	-1%	-$71K	2.31%	7
2023 Q3	$5.11M	Sell	34,302 -330	-1%	-$48.4K	2.43%	8
2023 Q2	$4.67M	Hold	34,632	–	–	2.11%	12
2023 Q1	$5.52M	Sell	34,632 -80	-0.2%	-$12.2K	2.64%	8
2022 Q4	$5.61M	Buy	34,712 +275	+0.8%	+$42.2K	2.75%	7
2022 Q3	$4.62M	Hold	34,437	–	–	2.48%	9
2022 Q2	$5.27M	Hold	34,437	–	–	2.62%	8
2022 Q1	$5.58M	Buy	34,437 +22	+0.1%	+$3.2K	2.45%	7
2021 Q4	$4.66M	Buy	34,415 +925	+3%	+$109K	1.95%	10
2021 Q3	$3.61M	Hold	33,490	–	–	1.68%	14
2021 Q2	$3.77M	Sell	33,490 -487	-1%	-$54.8K	1.77%	14
2021 Q1	$3.68M	Buy	33,977 +100	+0.3%	+$10.7K	1.78%	14
2020 Q4	$3.63M	Buy	33,877 +765	+2%	+$73.5K	1.92%	15
2020 Q3	$2.9M	Buy	33,112 +283	+0.9%	+$26.6K	1.68%	17
2020 Q2	$3.22M	Hold	32,829	–	–	1.99%	14
2020 Q1	$2.5M	Hold	32,829	–	–	1.8%	16
2019 Q4	$2.91M	Hold	32,829	–	–	1.66%	15
2019 Q3	$2.49M	Hold	32,829	–	–	1.56%	16
2019 Q2	$2.39M	Hold	32,829	–	–	1.52%	17
2019 Q1	$2.65M	Buy	32,829 +669	+2%	+$54.7K	1.67%	14
2018 Q4	$2.96M	Hold	32,160	–	–	2.1%	10
2018 Q3	$3.04M	Hold	32,160	–	–	1.8%	13
2018 Q2	$2.98M	Hold	32,160	–	–	1.88%	13
2018 Q1	$3.04M	Hold	32,160	–	–	1.89%	11
2017 Q4	$3.11M	Hold	32,160	–	–	1.89%	12
2017 Q3	$2.86M	Hold	32,160	–	–	1.85%	13
2017 Q2	$2.33M	Hold	32,160	–	–	2.07%	16
2017 Q1	$2.1M	Hold	32,160	–	–	1.89%	16
2016 Q4	$2.01M	Hold	32,160	–	–	1.92%	16
2016 Q3	$2.03M	Buy	32,160 +168	+0.5%	+$10.9K	1.96%	16
2016 Q2	$1.98M	Hold	31,992	–	–	1.92%	16
2016 Q1	$1.83M	Buy	31,992 +974	+3%	+$54.3K	1.89%	16
2015 Q4	$1.84M	Hold	31,018	–	–	1.77%	16
2015 Q3	$1.69M	Hold	31,018	–	–	1.77%	17
2015 Q2	$2.08M	Hold	31,018	–	–	2.03%	16
2015 Q1	$1.82M	Hold	31,018	–	–	1.76%	17
2014 Q4	$2.03M	Hold	31,018	–	–	1.95%	17
2014 Q3	$1.79M	Sell	31,018 -974	-3%	-$54.1K	1.76%	18
2014 Q2	$1.81M	Hold	31,992	–	–	1.64%	19
2014 Q1	$1.64M	Hold	31,992	–	–	1.55%	19
2013 Q4	$1.69M	Buy	+31,992	New	+$1.57M	1.59%	19

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pettee Investors's ABBV Position: Q2 2026 in Review

Pettee Investors held its AbbVie (ABBV) position steady in Q2 2026 at 12,370 shares worth $3.11M. The position accounts for 1.53% of the portfolio, ranked #16.

Pettee Investors first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. The position peaked at $6.16M in Q1 2024. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Pettee Investors held 12,370 shares of AbbVie worth $3.11M as of Q2 2026.
Pettee Investors left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 1.53% of Pettee Investors's portfolio in Q2 2026, its #16 holding.
Pettee Investors first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
Pettee Investors's AbbVie position peaked at $6.16M in Q1 2024.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pettee Investors's 13F filing for Q2 2026, filed 6 Aug 2026.